Domov › Skvamózny bunkový karcinóm pažeráka › New York
Klinické štúdie Skvamózny bunkový karcinóm pažeráka v štáte New York
14 štúdií pre Skvamózny bunkový karcinóm pažeráka hľadá účastníkov v zariadeniach v štáte New York.
Mestá v štáte New York
Oficiálny text štúdie (anglicky)
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- Hematology-Oncology Associates of Central NY, P.C. ( Site 4925), East Syracuse
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05319730A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07277413A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
- START New York, Lake Success
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT07730021A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07217171Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Research Site, New York
- Research Site, Stony Brook
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT06535607A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute, Buffalo
- START New York Long Island, Lake Success
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07602842A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT06242470A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
- Maimonides Cancer Center, Brooklyn
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06644781A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- START New York, Lake Success
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 7. 2026 · NCT06657144A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
- a 7 ďalších
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT04389632Study of XB010 in Subjects With Solid Tumors
- Montefiore Medical Center - Montefiore Medical Park, The Bronx
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT06545331A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- START New York Long Island, LLC, Lake Success
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 6. 2026 · NCT07503808First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, New York
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT07284186A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 107, New York
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 11. 2025 · NCT05914116Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.